scholarly journals Latest Evidence on Using Hormone Replacement Therapy in the Menopause

2018 ◽  
Vol 36 (1) ◽  
pp. 26-32
Author(s):  
Mst Jesmin Akter ◽  
Eliza Shirin

Hormone replacement therapy (HRT) is the most effective therapy of menopausal symptoms for perimenopausal and menopausal women. When HRT is individually tailored women gain maximum advantages and the risk are minimized. There are different types of hormones with different doses and different routes of delivery exist. . The use of HRT is an individual decision which women can only make once she has been given correct information and advice from healthcare professionals. HRT should be recommended in women with premature ovarian insufficiency with advice to continue until the average age of menopause at 51.4 years. This review item promotes confidence in prescribing HRT in most symptomatic women. Prescribing HRT in women with relative contraindication where evidence is limited. Quality of life is priority. Multidisciplinary approach may be necessary and informed written consent documented.J Bangladesh Coll Phys Surg 2018; 36(1): 26-32

e-CliniC ◽  
2013 ◽  
Vol 1 (1) ◽  
Author(s):  
Sitti Qamariah

Abstract: the increasing age of the life expectancy of women led to an increased number of women in Indonesia. There is a major problem confronting the elderly woman is menopause. On menopausal women will develop a variety of complaints. Complaints arising in menopausal women is a result of lack of estrogen, the hormone treatment by administering hormone is also known as Hormone Replacement Therapy Dubbed. The above things that encourage writers to research about the quality of life of menopausal women who use Hormone Replacement Therapy Dubbed rated with MENQOL (The Menopause Specific Quality of Life Questionnaire) was General Hospital Prof. Dr. r. d. Kandou Manado. This research is a descriptive cross sectional design using a MENQOL questionnaire consists of four domains, namely vasomotor menopausal symptoms, psychosocial, physical and sexual abuse. This research was conducted on menopausal women who use hormone therapy in English was Prof. Dr. R.D. Kandou Manado in November 2012. Of the 19 Research Subjects, obtained 52,63% experienced disruption of quality of life. Based on the symptoms, physical disorder group is the largest intrusion on the natural subjects of 84,21%. There was 52,63% of women who use Hormone Replacement Therapy in English was General Hospital Prof. Dr. R. D. Kandou Manado still experiencing disruption of quality of life based on measurement results using MENQOL.Keywords: Quality of life, menopause, hormone replacement therapy, MENQOLAbstrak: Meningkatnya usia harapan hidup wanita Indonesia menyebabkan peningkatan jumlah wanita lanjut usia. Ada masalah pokok yang dihadapi wanita lanjut usia yaitu menopause. Pada wanita menopause akan timbul berbagai keluhan. Keluhan yang timbul pada wanita menopause adalah akibat dari kekurangan hormone estrogen, maka pengobatannya pun adalah dengan pemberian hormone pengganti yang dikenal dengan Terapi Sulih Hormon. Hal-hal diatas yang mendorong penulis untuk meneliti tentang kualitas hidup wanita menopause yang menggunakan Terapi Sulih Hormon dinilai dengan MENQOL (The Menopause Spesific Quality of Life Questionnaire) di RSU Prof. DR. R. D. Kandou Manado. Penelitian ini bersifat deskriptif dengan desain cross sectional menggunakan kuesioner MENQOL yang terdiri dari empat domain gejala menopause yaitu vasomotor, psikososial, fisik dan seksual. Penelitian ini dilakukan pada wanita menopause yang menggunakan terapi sulih hormon di RSU Prof. DR. R.D. Kandou Manado pada bulan November 2012. Dari 19 Subyek Penelitian, didapatkan 52,63% mengalami gangguan kualitas hidup. Berdasarkan kelompok gejala, gangguan fisik merupakan gangguan terbanyak yang di alami subyek 84,21%. Terdapat 52,63% Wanita yang menggunakan terapi sulih hormon di RSU Prof. Dr. R. D. Kandou Manado masih mengalami gangguan kualitas hidup berdasarkan hasil pengukuran menggunakan MENQOL.Kata Kunci : Kualitas hidup, wanita menopause, Terapi Sulih Hormon, MENQOL


2017 ◽  
Vol 63 (6) ◽  
pp. 843-854
Author(s):  
Olga Novikova ◽  
Yelena Ulrikh ◽  
V. Nosov ◽  
A. Charkhifalakyan

There is presented the review of domestic and foreign references on the conserved oncological safety of the use of menopausal hormone therapy after treatment for endometrial cancer, cervical cancer, borderline and malignant ovarian tumors, various variants of sarcomas of the uterus, vulva and vaginal cancer. To the opinion of the authors the refusal to prescribe menopausal hormone therapy to patients with oncogynecologic diseases in the anamnesis is usually not justified, the category of patients, to whom hormone replacement therapy is contraindicated, is well described and mentioned in the text. In other cases sex hormones can be used to treat menopausal symptoms and improve the quality of life of patients.


2008 ◽  
Vol 122 (7) ◽  
pp. 707-710 ◽  
Author(s):  
D C Wild ◽  
C M Philpott ◽  
C R Wolstenholme ◽  
G E Murty

AbstractBackground:Previous studies have suggested that the female menstrual cycle, pregnancy and the oral contraceptive pill have an effect upon nasal physiology.Objectives:This study aimed to assess the effects upon nasal physiology of female hormone replacement therapy in post-menopausal women. This has not been previously studied.Methods:Twenty post-menopausal women (age range 36 to 70 years; mean age 57.0 years) underwent measurements of the nasal airway, including anterior rhinoscopy, peak nasal inspiratory flow rate, acoustic rhinometry, anterior rhinomanometry, mucociliary clearance time and rhinitis quality of life questionnaire. Measurements of nasal patency were recorded prior to commencing hormone replacement therapy and at a time point 77–195 days (mean 101.9 days) following commencement.Results:There was no statistical difference found for any of the variables, using the paired t-test (p > 0.05 for all).Conclusions:Female hormone replacement therapy has no discernable effect upon nasal physiology and should not be considered a cause of rhinitic symptoms.


Sign in / Sign up

Export Citation Format

Share Document